Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 5
2013 3
2014 16
2015 12
2016 13
2017 16
2018 17
2019 9
2020 10
2021 15
2022 13
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
The following term was ignored: (
Page 1
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.
Klümper N, Ralser DJ, Ellinger J, Roghmann F, Albrecht J, Below E, Alajati A, Sikic D, Breyer J, Bolenz C, Zengerling F, Erben P, Schwamborn K, Wirtz RM, Horn T, Nagy D, Toma M, Kristiansen G, Büttner T, Hahn O, Grünwald V, Darr C, Erne E, Rausch S, Bedke J, Schlack K, Abbas M, Zschäbitz S, Schwab C, Mustea A, Adam P, Manseck A, Wullich B, Ritter M, Hartmann A, Gschwend J, Weichert W, Erlmeier F, Hölzel M, Eckstein M. Klümper N, et al. Among authors: rausch s. Clin Cancer Res. 2023 Apr 14;29(8):1496-1505. doi: 10.1158/1078-0432.CCR-22-1764. Clin Cancer Res. 2023. PMID: 36534531 Free PMC article.
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
Büttner FA, Winter S, Stühler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, Meinhardt M, Toma M, Jerónimo C, Henrique R, Miranda-Gonçalves V, Kröger N, Ribback S, Hartmann A, Agaimy A, Stöhr C, Polifka I, Fend F, Scharpf M, Comperat E, Wasinger G, Moch H, Stenzl A, Gerlinger M, Bedke J, Schwab M, Schaeffeler E. Büttner FA, et al. Among authors: rausch s. Genome Med. 2022 Sep 15;14(1):105. doi: 10.1186/s13073-022-01105-y. Genome Med. 2022. PMID: 36109798 Free PMC article.
Author'S reply.
Sim A, Todenhöfer T, Mischinger J, Halalsheh O, Boettge J, Rausch S, Bier S, Aufderklamm S, Stenzl A, Gakis G, Schwentner C. Sim A, et al. Among authors: rausch s. Cent European J Urol. 2014;67(4):426. doi: 10.5173/ceju.2014.04.art23. Cent European J Urol. 2014. PMID: 25667769 Free PMC article. No abstract available.
Trimodal therapy for muscle-invasive bladder cancer.
Mathes J, Rausch S, Todenhöfer T, Stenzl A. Mathes J, et al. Among authors: rausch s. Expert Rev Anticancer Ther. 2018 Dec;18(12):1219-1229. doi: 10.1080/14737140.2018.1535314. Epub 2018 Oct 17. Expert Rev Anticancer Ther. 2018. PMID: 30324833 Review.
Pembrolizumab for the treatment of renal cell carcinoma.
Di Bona C, Stühler V, Rausch S, Stenzl A, Bedke J. Di Bona C, et al. Among authors: rausch s. Expert Opin Biol Ther. 2021 Sep;21(9):1157-1164. doi: 10.1080/14712598.2021.1935856. Epub 2021 Jun 3. Expert Opin Biol Ther. 2021. PMID: 34042015 Review.
Minimal-invasive management of urological complications after kidney transplantation.
Deininger S, Nadalin S, Amend B, Guthoff M, Heyne N, Königsrainer A, Strohäker J, Stenzl A, Rausch S. Deininger S, et al. Among authors: rausch s. Int Urol Nephrol. 2021 Jul;53(7):1267-1277. doi: 10.1007/s11255-021-02825-7. Epub 2021 Mar 2. Int Urol Nephrol. 2021. PMID: 33655463 Free PMC article. Review.
[Urinary bladder injuries. Diagnosis and treatment].
Rausch S, Amend B, Adam M, Stenzl A, Bedke J. Rausch S, et al. Urologe A. 2016 Apr;55(4):466-74. doi: 10.1007/s00120-016-0067-8. Urologe A. 2016. PMID: 27003570 Review. German.
116 results